Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
534.00
-19.15 (-3.46%)
Nov 3, 2026, 2:03 PM EST - Market open

Vertex Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
135,348132,512126,073113,436115,026100,413114,326124,497103,707120,038120,955107,975104,84989,75090,63581,00274,12774,25572,06966,43755,834
Market Cap Growth (YoY)
24.04%31.97%10.27%-8.88%10.91%-16.35%-5.48%15.30%-1.09%33.75%33.45%33.30%41.44%20.87%25.76%21.92%32.76%57.80%38.08%18.93%-9.15%
Enterprise Value
132,005120,848115,063103,152104,85189,912104,618115,02394,253110,783107,12395,06891,96577,92479,92971,12365,18165,84964,70459,87949,750
Last Close Price
553.15522.81496.73446.54453.36391.64445.20484.82402.70465.08468.72418.01406.89347.74351.91315.07288.78289.54281.79260.97219.60

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
34.3433.3328.6226.1529.1027.3231.43-125.89-193.63-250.18-26.8628.9725.8726.9424.8522.3122.6922.5627.1123.84
Forward PE
27.5938.1925.3623.3122.6120.3223.6026.8822.6626.3928.0724.8524.4421.9222.7021.8918.8319.6719.4518.1216.42
PS Ratio
10.8310.2310.029.289.588.5710.0111.229.4111.3011.7010.6010.629.309.548.808.308.548.638.367.37
PB Ratio
6.716.346.235.866.165.806.667.556.327.688.195.825.965.445.865.615.335.706.046.095.53
P/TBV Ratio
14.0713.306.736.356.716.367.308.327.158.769.416.506.706.066.586.366.076.546.846.996.42
P/FCF Ratio
36.93-33.2130.5736.0230.0932.67-99.57-131.22-108.55-29.0531.4221.3423.3720.8218.8919.4719.0327.1123.18
P/OCF Ratio
32.66-29.3726.7531.6827.0129.72-127.00-210.53-142.46-27.3829.6420.4922.2819.8917.9518.3517.9424.8021.12
PEG Ratio
2.372.862.021.680.150.130.730.841.210.751.040.781.921.712.000.760.580.670.580.771.62

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
10.579.339.148.448.747.679.1610.368.5510.4310.369.339.328.078.417.727.307.577.757.536.57
EV/EBITDA Ratio
29.6626.1922.5620.7121.5519.0822.7226.2220.5924.9124.3720.7420.5417.0517.2715.4014.4014.7414.7414.3412.39
EV/EBIT Ratio
30.9627.3423.4421.5122.3719.8223.6227.3221.4526.1425.5221.6121.3517.6717.8815.9214.8915.2315.2214.8112.79
EV/FCF Ratio
36.05-30.3127.8032.8326.9429.89-92.00-119.26-100.18-25.5727.5618.5320.6118.2816.6117.2717.0924.4320.66

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.310.310.100.100.110.110.090.100.110.110.060.040.050.050.050.060.070.060.070.080.10
Debt / EBITDA Ratio
1.311.870.360.400.380.350.310.370.370.370.230.140.200.160.160.170.200.170.180.200.23
Debt / FCF Ratio
--0.520.540.640.550.44-1.32-2.21-1.60-0.190.240.180.200.200.230.220.220.360.40
Net Debt / Equity Ratio
-0.16-0.16-0.58-0.57-0.55-0.59-0.61-0.59-0.58-0.60-0.63-0.75-0.73-0.78-0.76-0.74-0.72-0.69-0.70-0.67-0.65
Net Debt / EBITDA Ratio
-0.72-0.72-2.29-2.21-2.11-2.16-2.28-2.21-2.07-2.13-2.11-3.02-2.88-2.82-2.56-2.32-2.21-2.00-1.91-1.76-1.63
Net Debt / FCF Ratio
---3.07-2.97-3.22-3.05-3.007.7711.998.557.84-3.72-3.87-3.06-3.05-2.75-2.54-2.35-2.22-3.00-2.72
Asset Turnover
0.450.450.490.500.500.500.520.470.490.480.510.480.480.500.530.550.570.590.600.600.60
Inventory Turnover
2.991.053.363.143.483.563.884.194.985.096.205.836.686.997.698.119.219.899.619.799.50
Quick Ratio
1.721.722.542.382.241.842.002.122.172.082.103.153.603.743.823.954.464.284.144.374.04
Current Ratio
2.342.343.193.022.902.362.522.652.692.472.523.503.994.084.144.284.834.704.504.754.46
Return on Equity (ROE)
20.80%20.80%23.54%24.20%22.54%22.31%22.77%-5.64%-3.15%-2.99%-3.24%24.38%22.99%23.49%24.56%25.73%27.67%29.02%30.24%24.65%24.93%
Return on Assets (ROA)
9.59%9.59%11.93%12.14%12.16%12.04%12.53%11.24%12.14%12.05%12.96%12.82%13.17%14.34%15.56%16.80%17.33%18.43%19.12%19.17%19.32%
Return on Invested Capital (ROIC)
20.83%21.77%30.75%30.95%30.65%31.74%33.30%35.24%39.98%46.32%50.23%53.31%63.25%75.23%81.95%83.72%90.77%93.50%100.15%107.33%103.28%
Return on Capital Employed (ROCE)
15.90%15.90%20.90%21.20%21.50%22.30%22.30%22.00%23.20%23.20%25.30%21.90%22.50%24.30%26.30%28.00%28.40%30.70%32.60%33.50%34.50%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
2.91%3.00%3.49%3.82%3.44%3.66%3.18%-0.79%-0.52%-0.40%-0.40%3.72%3.45%3.87%3.71%4.02%4.48%4.41%4.43%3.69%4.20%
FCF Yield
2.71%-3.01%3.27%2.78%3.32%3.06%-1.00%-0.76%-0.92%-0.98%3.44%3.18%4.69%4.28%4.80%5.29%5.14%5.25%3.69%4.31%
Buyback Yield / Dilution
1.01%0.93%1.43%1.23%1.69%1.30%-0.31%0.61%0.15%-0.15%0.88%-0.31%-0.23%-0.42%-0.66%-0.93%-1.28%0.08%0.88%1.53%2.32%
SEC Filings: 10-K · 10-Q